Sally Parrott joins the KITS Board as a seasoned leader with deep experience scaling high-growth consumer brands through periods of rapid expansion. She brings over two decades of brand, digital, and ...

The 'Game of Thrones' alum is a dad to two children — a boy and a girl Kayla Grant is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2025. Her work has previously appeared in ...

Universal Hall in FIndhorn has announced a stellar addition to its upcoming season with the arrival of James Yorkston’s acclaimed travelling club night ‘Tae Sup Wi’ a Fifer’ Hosted and programmed by ...

Despite the maelstrom arising from the infamous series finale of HBO‘s prestige hit Game of Thrones, star Kit Harington says he took issue with viewers’ audacious petition to remake the ending “with ...

Doha: The Qatar Kite Festival, one of the country’s most anticipated winter events, is set to return to Doha in January 2026 for its fourth edition, bringing together internationally renowned kite ...

Every holiday season, millions of Americans hop on a plane to visit friends and family. Most people are anxious about flight delays and cancellations, but as an emergency room physician, there’s one ...

RFT Writers are a collective of independent journalists contributing original reporting to RFT. They report on a wide range of topics including music, news, gaming, cannabis, and the creator economy.

The original Isle Switch SUP/Kayak hybrid was one of the most versatile paddlecrafts ever built, because it worked well in either modes. The new and improved Isle Switch Pro is designed to take ...

The best inflatable stand-up paddleboards (SUPs) that fit in a backpack, but are stable enough for coastal adventures Siân is an award-winning travel and outdoors journalist and author based in the ...

Put down your broomsticks and pick up the paddle! Vancouver’s fifth Annual Witchilano SUP Paddle is on Saturday, October 5th at 11am and takes off from Kitsilano Beach. Witchilano organizers request ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...